Tapeworms (Cestoda) cause neglected diseases that can be fatal and are difficult to treat, owing to inefficient drugs. Here we present an analysis of tapeworm genome sequences using the human-infective species Echinococcus multilocularis, E. granulosus, Taenia solium and the laboratory model Hymenolepis microstoma as examples. The 115- to 141-megabase genomes offer insights into the evolution of parasitism. Synteny is maintained with distantly related blood flukes but we find extreme losses of genes and pathways that are ubiquitous in other animals, including 34 homeobox families and several determinants of stem cell fate. Tapeworms have specialized detoxification pathways, metabolism that is finely tuned to rely on nutrients scavenged from their hosts, and species-specific expansions of non-canonical heat shock proteins and families of known antigens. We identify new potential drug targets, including some on which existing pharmaceuticals may act. The genomes provide a rich resource to underpin the development of urgently needed treatments and control.
Echinococcosis (hydatid disease) and cysticercosis, caused by the proliferation of larval tapeworms in vital organs1, are among the most severe parasitic diseases in humans and account for 2 of the 17 neglected tropical diseases prioritized by the World Health Organization2. Larval tapeworms can persist asymptomatically in a human host for decades3, eventually causing a spectrum of debilitating pathologies and death1. When diagnosed, the disease is often at an advanced stage at which surgery is no longer an option4. Tapeworm infections are highly prevalent worldwide5, and their human disease burden has been estimated at 1 million disability-adjusted life years, comparable with African trypanosomiasis, river blindness and dengue fever. Furthermore, cystic echinococcosis in livestock causes an annual loss of US$2 billion6.
Tapeworms (Platyhelminthes, Cestoda) are passively transmitted between hosts and parasitize virtually every vertebrate species7. Their morphological adaptations to parasitism include the absence of a gut, a head and light-sensing organs, and they possess a unique surface (tegument) that is able to withstand host-stomach acid and bile but is still penetrable enough to absorb nutrients7.
Tapeworms are the only one of three major groups of worms that parasitize humans, the others being flukes (Trematoda) and round worms (Nematoda), for which no genome sequence has been available so far. Here we present a high-quality reference tapeworm genome of a human-infective fox tapeworm Echinococcus multilocularis. We also present the genomes of three other species, for comparison; E. granulosus (dog tapeworm), Taenia solium (pork tapeworm), both of which infect humans, and Hymenolepis microstoma (a rodent tapeworm and laboratory model for the human parasite Hymenolepis nana). We have mined the genomes to provide a starting point for developing urgently needed therapeutic measures against tapeworms and other parasitic flatworms. Access to the complete genomes of several tapeworms will accelerate the pace at which new tools and treatments to combat tapeworm infections can be discovered.
The genomes and genes of tapeworms
The E. multilocularis genome assembly was finished manually (Supplementary Information, section 2), producing a high-quality reference genome in which 89% of the sequence is contained in 9 chromosome scaffolds that have only 23 gaps (Supplementary Table 1.2). One chromosome is complete from telomere to telomere, and 13 of the expected 18 telomeres are joined to scaffolds (Fig. 1a). This quality and completeness is comparable to that of the first publications of Caenorhabditis elegans and Drosophila melanogaster genomes8,9. The 115- to 141-megabase (Mb) nuclear tapeworm genomes were sequenced using several high-throughput technologies (Supplementary Table 1.1). The tapeworm genomes are approximately one-third of the size of the genome of their distant flatworm relative, the blood fluke Schistosoma mansoni10, mainly because it has fewer repeats (Supplementary Information, section 3). By sequencing several isolates of E. multilocularis (Supplementary Table 3.2), we revealed tetraploidy in protoscoleces of one isolate, and a trisomy of chromosome 9 (the smallest chromosome, and possibly the only one for which a trisomy is tolerated) transiently exhibited in protoscoleces and metacestodes from two different isolates (Fig. 1c, d and Supplementary Figs 3.1, 3.2 and 3.3), consistent with previous observations of karyotype plasticity in flatworms11.
Aided by deep transcriptome sequencing from multiple life-cycle stages, we identified 10,231 to 12,490 putative genes per genome (Supplementary Table 5.5). Similar to the genome of S. mansoni12, distinct ‘micro-exon genes’ are present in tapeworm genomes, with multiple internal exons that are small (typically less than 36 bases) and divisible by 3 (Supplementary Information, section 5). To identify gene gain and loss in tapeworms, orthologous relationships were predicted between tapeworms and eight other species (Fig. 2). Although gene order has been lost, ancient chromosomal synteny is preserved among parasitic flatworms (Fig. 1b and Supplementary Table 7.3). Two chromosomes in E. multilocularis (Fig. 1a, b) correspond to the S. mansoni Z sex chromosome. Schistosomes are unusual among flatworms in that they have sexual dimorphism, but how common ancestors of both tapeworms and flukes evolved into female-heterogametic parasites, like S. mansoni, remains to be elucidated.
Genome-wide identification of polycistrons in tapeworms shows that there are 308 putative polycistrons in E. multilocularis, with the largest containing 4 genes. The internal gene order within E. multilocularis polycistrons is largely the same as in T. solium and H. microstoma (Supplementary Table 6.5), and—to some extent—as in flukes; 39% of S. mansoni orthologues of genes within E. multilocularis polycistrons retain colinearity. Of these S. mansoni genes, 40% have transcriptome evidence supporting their polycistronic transcription10, demonstrating further that gene order in polycistrons is highly conserved over long evolutionary time13 (P < 0.0001, Supplementary Information, section 6).
Polycistrons are resolved into individual coding transcripts using spliced-leader trans-splicing, but spliced-leader trans-splicing also occurs in genes outside of polycistrons. Using deep transcriptome sequencing (RNA-seq) we found evidence of spliced-leader trans-splicing in approximately 13% of E. multilocularis genes (Supplementary Table 6.2), less than the 70% observed in C. elegans14 and 58% in a tunicate15.
Specialized metabolism and detoxification
The high-confidence gene sets reveal extensive reductions in overall metabolic capability and an increased ability to absorb nutrients, compared to that of other animals (Figs 2 and 3, and Supplementary Information, section 9). Their main energy source, carbohydrates, can be catabolized by aerobic respiration or by two complementary anaerobic pathways; the lactate fermentation and malate dismutation pathways. The parasiticidal effects of mitochondrial fumarate reductase inhibitors have been demonstrated in vitro, suggesting that the malate dismutation pathway would be an effective target for the development of novel therapeutics16.
Tapeworms, like flukes, lack the ability to synthesize fatty acids and cholesterol de novo17,18. Instead, they scavenge essential fats from the host using fatty acid transporters and lipid elongation enzymes (Supplementary Table 9.2), as well as several tapeworm-specific gene families, such as fatty acid binding protein (FABP) and the apolipoprotein antigen B (Supplementary Information, section 8). Uptake of fatty acids seems to be crucial in Echinococcus spp. metacestodes, in which both FABP and antigen B gene families are among the most highly expressed genes19 (Supplementary Table 5.7). Tapeworms and flukes have lost many genes associated with the peroxisome (Supplementary Information, section 8), an organelle in which fatty acid oxidation occurs, and may lack peroxisomes altogether, as seen in several other parasites20.
Compared with other animals, S. mansoni has a reduced ability to synthesize amino acids17. In tapeworms, this capacity is reduced further, with serine and proline biosynthesis enzymes absent from E. multilocularis (Fig. 3 and Supplementary Information, section 9). Many enzymes in the molybdopterin biosynthesis pathway seemed to be lost in tapeworms, along with enzymes that use molybdopterin as a cofactor. The ability to utilize molybdenum in enzymatic reactions was believed to be present in all animals21, but has been lost in some eukaryotic parasites22.
Differences in the detoxification systems between tapeworms and their mammalian hosts may be exploited for drug design (Supplementary Information, section 9). We found that, like flukes23, tapeworms typically have only one cytochrome P450 gene, suggesting that their ability to oxidize many xenobiotics and steroids is substantially lower than that of their hosts. Uniquely, tapeworms and flukes have merged two key enzymatic functions for redox homeostasis in one single enzyme: thioredoxin glutathione reductase (TGR). TGR is an essential gene and validated drug target in flukes24. Downstream of TGR we find an unexpected diversity of thioredoxins, glutaredoxins and mu-class glutathione S-transferases (GSTs) (Supplementary Table 9.3). The GST expansion suggests that tapeworms would be able to water-solubilize and excrete a large range of hydrophobic compounds, which may add complexity to the pharmacokinetics of drugs.
Homeobox gene loss
Homeobox genes are high-level transcription factors that are implicated in the patterning of body plans in animals. Across parasitic flatworms, the homeobox gene numbers are extensively reduced (Supplementary Table 10.1). Most bilaterian invertebrates have a conserved set of approximately 100 homeobox genes (for example, 92 conserved in C. elegans, 102 in D. melanogaster, and 133 in the lancelet)25. Of the 96 homeobox gene families that are thought to have existed at the origin of the Bilateria, 24 are not present in tapeworms and flukes, and a further 10 were lost in tapeworms, making their complement by far the most reduced of any studied bilaterian animal25. Among the tapeworm-specific gene losses are gene families involved in neural development (mnx, pax3/7, gbx, hbn and rax). This is somewhat surprising considering that tapeworms possess a well-developed nervous system, albeit with reduced sensory input and cephalization. Tapeworms also lack the ParaHox genes (gsx, pdx, cdx) ancestrally involved in specification of a through-gut26,27, although these seem to have been lost before the tapeworm gut was lost. Other conserved genes found in bilaterian developmental pathways such as Hedgehog and Notch were found to be present and intact, although the Wnt complement is greatly reduced compared to the ancestral (spiralian) complement of 12 Wnt ligands28 (Supplementary Table 10.2).
Stem cell specializations
Extreme regenerative capability and developmental plasticity, mediated by ever-present somatic stem cells (neoblasts), have made flatworms popular models for stem cell research29. All multicellular organisms rely on stem cells for proliferation and growth, so it is remarkable that tapeworms and flukes appear to lack the ubiquitous stem cell marker gene vasa (Supplementary Information, section 11). Instead tapeworms have two copies of another dead-box helicase (PL10), which we propose may have taken over some of the functions of vasa (Supplementary Fig. 11.1). Tapeworms and flukes are also missing the piwi gene subfamily and piwi-interacting tudor-domain containing proteins. The piwi genes belong to a subfamily of genes encoding argonaute proteins, and we also found that tapeworms have a new subfamily of argonaute proteins (Supplementary Fig. 11.2) that may bind a newly discovered potential small RNA precursor30. Both piwi and vasa are usually essential in regulating the fate of germline stem cells in animals, and vasa suppression usually leads to infertility or death31. These findings suggest that stem-cell-associated pathways in parasitic flatworms may be highly modified.
Specialization of the tapeworm proteome
We sought to identify novel and expanded gene families in tapeworms, and found many frequently occurring novel domains involved in cell–cell adhesion and the formation of the tegument (Supplementary Information, section 8). For example, several novel domains are found on the ectodomain of cadherins (Supplementary Information, section 8), and tapeworms have proportionally more tetraspanin copies (30–36) (Supplementary Table 12.1) than the highly expanded repertoires of fruitflies and zebrafish32. The acellular carbohydrate-rich laminated layer, which coats the outside of Echinococcus metacestodes, is a unique genus-specific trait and one of the few morphological traits that differ between the very closely related species E. granulosus and E. multilocularis. We identified corresponding species differences in an Echinococcus-specific apomucin family (Supplementary Fig. 12.1), an important building block of the laminated layer33. One particular copy is highly differentiated between the two species (non-synonymous to synonymous substitution ratio of >1) and is the fifth most highly expressed in the metacestode stage of E. multilocularis (Supplementary Table 5.7). Galactosyltransferases that probably decorate the apomucins with galactose residues, the predominant sugar of laminated layer glycans, are similarly diverged33 (Supplementary Information, section 8). Approximately 20% of the genes are exclusive to tapeworms, and these include many highly expressed antigen families, such as antigen B, the glycosylphosphatidylinositol (GPI)-anchored protein GP50 (ref. 34), and the vaccine target EG95 (ref. 35) (Supplementary Table 12.4).
One of the most striking gene family expansions in the tapeworm genomes is the heat shock protein 70 (Hsp70) family. Phylogenetic analysis revealed independent and parallel expansions in both the Hsp110 and the cytosolic Hsp70 clades (Fig. 4). Several examples of expansions exist at various clades of Hsp70 in other systems, including Hsp110 expansions in oysters (to cope with temperature) and in cancer cells (to cope with proteotoxic stress)36,37. Echinococcus and T. solium have the highest number of gene expansions in the cytosolic Hsp70 clade. These expansions seem to have occurred independently in each species, and have resulted in 22 to 32 full copies in each species (Echinococcus and T. solium) compared to 6 copies in fruitflies and 2 in humans (Fig. 4). This expanded clade lacks classical cytosolic Hsp70 features (a conserved EEVD motif for substrate binding and a GGMP repeat unit), and whereas the canonical cytosolic hsp70 genes are constitutively expressed in different life-cycle stages, the non-canonical genes show almost no expression, suggesting a putative contingency role in which individual copies of the expanded family are only highly expressed under certain conditions (Supplementary Fig. 12.2). At least 40% of E. multilocularis hsp70-like genes are found within the subtelomeric regions of chromosomes, including the extreme case of chromosome 8 in which eight copies (including pseudogenes) are located in the subtelomere (Supplementary Table 12.2). No other genes are over-represented in these regions. Although Hsp70 proteins have been found in excretory–secretory products of tapeworms38, it remains to be determined whether the non-canonical Hsps have a host-interacting role or whether telomere proximity is important for their function or expression.
Novel drug targets
Tapeworm cysts are treated by chemotherapy or surgical intervention depending on tapeworm species, patient health and the site of the cyst. The only widely used drugs to treat tapeworm cysts are benzimidazoles39 that, owing to considerable side effects, are administered at parasitistatic rather than parasiticidal concentrations40. Novel targets and compound classes are therefore urgently needed.
To identify new potential drug targets, we surveyed common targets of existing pharmaceuticals; kinases, proteases, G-protein-coupled receptors (GPCRs) and ion channels41. We identified approximately 250 to 300 new protein kinases (Supplementary Table 13.1), and these cover most major classes (Supplementary Information, section 13). We also identified 151 proteases and 63 peptidase-like proteins in E. multilocularis, a repertoire of similar diversity to S. mansoni, and found that, like S. mansoni, E. multilocularis has strongly reduced copy numbers compared to those of other animals (Supplementary Table 13.9). Many successful anthelminthic drugs target one of several different forms of neural communication41. We therefore mapped the signalling pathways of the serotonin and acetylcholine neurotransmitters, predicted conserved and novel neuropeptides (Supplementary Table 13.6), and classified more than 60 putative GPCRs (Supplementary Table 13.2) and 31 ligand-gated ion channels (Supplementary Table 13.4). A voltage-gated calcium channel subunit42—the proposed target of praziquantel—is not expressed in cysts and thus provides a putative explanation for the drug’s low efficacy.
We searched databases for potential features for target selection, including compounds associated with protein targets and expression in the clinically relevant metacestode life-stage, and using this information we assigned weights to rank the entire proteomes (Supplementary Table 13.10). We identified 1,082 E. multilocularis proteins as potential targets, and of these, 150 to 200 with the highest scores have available chemical leads (known drug or approved compounds).
Acetylcholinesterases, which are inhibited by mefloquine (an anti-malarial that reduces egg production in S. mansoni), are high on the list of potential targets43. However, acetylcholinesterase transcription in tapeworm cysts is low, possibly limiting their suitability. After filtering to remove targets with common substrates rather than inhibitors, the top of the list includes several homologues of targets for cancer chemotherapy, including casein kinase II, ribonucleoside reductase, UMP–CMP kinase and proteasome subunits (Table 1). The challenges of inhibiting cancer tumours and metacestodes (particularly those of E. multilocularis) with drugs are in some ways similar; both show uncontrolled proliferation, invasion and metastasis, and are difficult to kill without causing damage to the surrounding tissue. Therefore, metacestodes may be vulnerable to similar strategies as cancer; suppression of mitosis, induction of apoptosis and prevention of DNA replication. In fact, the anthelminthic medicines niclosamide, mebendazole and albendazole have already been shown to inhibit cancer growth44.
Tapeworms were among the first known parasites of humans, recorded by Hippocrates and Aristotle in ∼300 bc (ref. 45), but a safe and efficient cure to larval tapeworm infection in humans has yet to be found. These genomes provide hundreds of potential drug targets that can be tested using high-throughput drug screenings that were made possible by recent advances in axenic and cell culturing techniques39,46,47. Flatworms display an unusually high degree of developmental plasticity. In this study, the high level of sequence completion enabled both gene losses and gains to be accurately determined, and has shown how this plasticity has been put to use in the evolution of tapeworms.
Genome sequencing was carried out using a combination of platforms. RNA sequencing was performed with Illumina RNA-seq protocols (for E. multilocularis, E. granulosus and H. microstoma) or capillary sequencing of full-length complementary DNA libraries (T. solium). The complete genome annotation is available at http://www.genedb.org. The tapeworm genome projects were registered under the INSDC project IDs PRJEB122 (E. multilocularis), PRJEB121 (E. granulosus), PRJEB124 (H. microstoma) and PRJNA16816 (T. solium). Sequence data for T. solium isolate (from Mexico) were used for all orthologue comparisons, but results relating to gene gains and losses were reconciled against an additional sequenced isolate from China (unpublished). All experiments involving jirds (laboratory host of E. multilocularis) were carried out in accordance with European and German regulations relating to the protection of animals. Ethical approval of the study was obtained from the ethics committee of the government of Lower Franconia (621-2531.01-2/05). Experiments with dogs (host of E. multilocularis sample RNA-seq ERS018054) were conducted according to the Swiss guidelines for animal experimentation and approved by the Cantonal Veterinary Office of Zurich prior to the start of the study, and were carried out with facility-born animals at the experimental units of the Vetsuisse Faculty in Zurich (permission numbers 40/2009 and 03/2010). A licensed hunter hunted the fox (host of E. multilocularis sample RNA-seq ERS018053) during the regular hunting season. Hymenolepis parasites were reared using laboratory mice in accordance with project license PPL 70/7150, granted to P.D.O. by the UK Home Office.
European Nucleotide Archive
Expressed Sequence Tag Database
The tapewormgenome projects were registered under the INSDC project IDs PRJEB122 (E. multilocularis), PRJEB121 (E. granulosus), PRJEB124 (H. microstoma) and PRJNA16816 (T. solium, Mexico). Illumina and 454 data are released to the European Nucleotide Archive (http://www.ebi.ac.uk/ena/) under accession numbers ERP000351, ERP000452 and PRJNA16816. Capillary data is at http://www.ncbi.nlm.nih.gov/Traces/trace.cgi, SEQ_LIB_ID 98488, 98489 and 101760, CENTER NAME SC (E. multilocularis) and sg1, sg2, sg3, sg4 and sg5 (T. solium, Mexico). Genome data are available from http://www.sanger.ac.uk/resources/downloads/helminths/ (E. multilocularis, E. granulosus and H. microstoma) and http://www.taeniasolium.unam.mx/taenia/ (T. solium). The complete genome annotation is available at http://www.genedb.org. All RNA-seq data were released to ArrayExpress under accession numbers E-ERAD-50 or E-ERAD-56. T. solium EST sequences were released to http://www.ncbi.nlm.nih.gov/nucest/, under accession numbers EL740221 to EL763490.
Garcia, H. H., Moro, P. L. & Schantz, P. M. Zoonotic helminth infections of humans: echinococcosis, cysticercosis and fascioliasis. Curr. Opin. Infect. Dis. 20, 489–494 (2007)
World Health Organization. Neglected Tropical Diseases (http://www.who.int/neglected_diseases/diseases/en/) (2012)
Eckert, J. & Deplazes, P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin. Microbiol. Rev. 17, 107–135 (2004)
Brunetti, E., Kern, P. & Vuitton, D. A. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 114, 1–16 (2010)
Budke, C. M., White, A. C., Jr & Garcia, H. H. Zoonotic larval cestode infections: neglected, neglected tropical diseases? PLoS Negl. Trop. Dis. 3, e319 (2009)
Torgerson, P. R. & Macpherson, C. N. The socioeconomic burden of parasitic zoonoses: global trends. Vet. Parasitol. 182, 79–95 (2011)
Burton, J., Bogitsh, C. E. C. & Oeltmann, T. N. Human parasitology. 4th edn (Academic Press, 2012)
Adams, M. D. et al. The genome sequence of Drosophila melanogaster. Science 287, 2185–2195 (2000)
The C. elegans Sequencing Consortium. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 282, 2012–2018 (1998)
Protasio, A. V. et al. A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni. PLoS Negl. Trop. Dis. 6, e1455 (2012)
Špakulová, M., Orosova, M. & Mackiewicz, J. S. Cytogenetics and chromosomes of tapeworms (Platyhelminthes, Cestoda). Adv. Parasitol. 74, 177–230 (2011)
DeMarco, R. et al. Protein variation in blood-dwelling schistosome worms generated by differential splicing of micro-exon gene transcripts. Genome Res. 20, 1112–1121 (2010)
Qian, W. & Zhang, J. Evolutionary dynamics of nematode operons: easy come, slow go. Genome Res. 18, 412–421 (2008)
Allen, M. A., Hillier, L. W., Waterston, R. H. & Blumenthal, T. A global analysis of C. elegans trans-splicing. Genome Res. 21, 255–264 (2011)
Matsumoto, J. et al. High-throughput sequence analysis of Ciona intestinalis SL trans-spliced mRNAs: alternative expression modes and gene function correlates. Genome Res. 20, 636–645 (2010)
Matsumoto, J. et al. Anaerobic NADH-fumarate reductase system is predominant in the respiratory chain of Echinococcus multilocularis, providing a novel target for the chemotherapy of alveolar echinococcosis. Antimicrob. Agents Chemother. 52, 164–170 (2008)
Berriman, M. et al. The genome of the blood fluke Schistosoma mansoni. Nature 460, 352–358 (2009)
Frayha, G. J. Comparative metabolism of acetate in the taeniid tapeworms Echinococcus granulosus, E. multilocularis and Taenia hydatigena. Comp. Biochem. Physiol. B 39, 167–170 (1971)
Obal, G. et al. Characterisation of the native lipid moiety of Echinococcus granulosus antigen B. PLoS Negl. Trop. Dis. 6, e1642 (2012)
Kaasch, A. J. & Joiner, K. A. Targeting and subcellular localization of Toxoplasma gondii catalase. Identification of peroxisomes in an apicomplexan parasite. J. Biol. Chem. 275, 1112–1118 (2000)
Schwarz, G. & Mendel, R. R. Molybdenum cofactor biosynthesis and molybdenum enzymes. Annu. Rev. Plant Biol. 57, 623–647 (2006)
Zhang, Y., Rump, S. & Gladyshev, V. N. Comparative Genomics and Evolution of Molybdenum Utilization. Coord. Chem. Rev. 255, 1206–1217 (2011)
Pakharukova, M. Y. et al. Cytochrome P450 in fluke Opisthorchis felineus: identification and characterization. Mol. Biochem. Parasitol. 181, 190–194 (2012)
Kuntz, A. N. et al. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Med. 4, e206 (2007)
Zhong, Y. F. & Holland, P. W. HomeoDB2: functional expansion of a comparative homeobox gene database for evolutionary developmental biology. Evol. Dev. 13, 567–568 (2011)
Holland, P. W. Beyond the Hox: how widespread is homeobox gene clustering? J. Anat. 199, 13–23 (2001)
Brooke, N. M., Garcia-Fernandez, J. & Holland, P. W. The ParaHox gene cluster is an evolutionary sister of the Hox gene cluster. Nature 392, 920–922 (1998)
Riddiford, N. & Olson, P. D. Wnt gene loss in flatworms. Dev. Genes Evol. 221, 187–197 (2011)
Brehm, K. Echinococcus multilocularis as an experimental model in stem cell research and molecular host-parasite interaction. Parasitology 137, 537–555 (2010)
Parkinson, J. et al. A transcriptomic analysis of Echinococcus granulosus larval stages: implications for parasite biology and host adaptation. PLoS Negl. Trop. Dis. 6, e1897 (2012)
Raz, E. The function and regulation of vasa-like genes in germ-cell development. Genome Biol. 1, R1017.1–R1017.6 (2000)
Garcia-España, A. et al. Appearance of new tetraspanin genes during vertebrate evolution. Genomics 91, 326–334 (2008)
Díaz, A. et al. Understanding the laminated layer of larval Echinococcus I: structure. Trends Parasitol. 27, 204–213 (2011)
Hancock, K. et al. Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis. Mol. Biochem. Parasitol. 133, 115–124 (2004)
Heath, D. D., Jensen, O. & Lightowlers, M. W. Progress in control of hydatidosis using vaccination - a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes. Acta Trop. 85, 133–143 (2003)
Zhang, G. et al. The oyster genome reveals stress adaptation and complexity of shell formation. Nature 490, 49–54 (2012)
Subjeck, J. R. & Repasky, E. A. Heat shock proteins and cancer therapy: the trail grows hotter!. Oncotarget 2, 433–434 (2011)
Vargas-Parada, L., Solis, C. F. & Laclette, J. P. Heat shock and stress response of Taenia solium and T. crassiceps (Cestoda). Parasitology 122, 583–588 (2001)
Hemphill, A. et al. Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes. Parasitology 137, 569–587 (2010)
Brunetti, E. & White, A. C., Jr Cestode infestations: hydatid disease and cysticercosis. Infect. Dis. Clin. North Am. 26, 421–435 (2012)
McVeigh, P. et al. Parasite neuropeptide biology: Seeding rational drug target selection? Int. J. Parasitol.. Drugs and Drug Res. 2, 76–91 (2012)
Marks, N. J. & Maule, A. G. Neuropeptides in helminths: occurrence and distribution. Adv. Exp. Med. Biol. 692, 49–77 (2010)
Van Nassauw, L., Toovey, S., Van Op den Bosch, J., Timmermans, J. P. & Vercruysse, J. Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice. Travel Med. Infect. Dis. 6, 253–258 (2008)
Doudican, N., Rodriguez, A., Osman, I. & Orlow, S. J. Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. Mol. Cancer Res. 6, 1308–1315 (2008)
Grove, D. I. A History of Human Helminthology. 848 (CAB International, 1990)
Spiliotis, M. & Brehm, K. Axenic in vitro cultivation of Echinococcus multilocularis metacestode vesicles and the generation of primary cell cultures. Methods Mol. Biol. 470, 245–262 (2009)
Spiliotis, M. et al. Echinococcus multilocularis primary cells: improved isolation, small-scale cultivation and RNA interference. Mol. Biochem. Parasitol. 174, 83–87 (2010)
We thank M. Dunn and OpGen for the E. multilocularis optical map; Roche for 20kb 454 libraries; R. Rance, M. Quail, D. Willey, N. Smerdon and K. Oliver for sequencing libraries at WTSI; T. D. Otto for bioinformatics expertise; R. Davies and Q. Lin for help with data release; A. Bateman, M. Punta, P. Cogghill and J. Minstry of Pfam; N. Rowlings from MEROPS database, J. Gough at SUPERFAMILY and C. Dessimoz for OMA; C. Seed and F. Jarero for laboratory assistance; J. Overington and B. Al-Lazikani; and B. Brejová for predicting genes with ExonHunter. P.D.O. and N.P.S. were supported in part by a BBSRC grant (BBG0038151) to P.D.O. P.D.O. and Ma.Z. were supported by a SynTax joint UK Research Council grant. The European Research Council supported P.W.H.H. and J.Paps. J.Parkinson and S.S.H. were supported by an operating grant from the Canadian Institute for Health Research (CIHR MOP#84556). G.S. was supported by FIRCA-NIH (grant TW008588) and the Universidad de la República, CSIC (grant CSIC 625). The E. multilocularis, E. granulosus and H. microstoma genome projects were funded by the Wellcome Trust through their core support of the Wellcome Trust Sanger Institute (grant 098051). K.B. was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; BR2045/4-1). The Taenia solium Genome Project (IMPULSA 03) was supported by the Universidad Nacional Autonóma de México. The Taenia solium Genome Consortium thanks P. de la Torre, J. Yañez, P. Gaytán, S. Juárez and J. L. Fernández for technical support; L. Herrera-Estrella and LANGEBIO, CINVESTAV-Irapuato and C. B. Shoemaker for sequencing support and other advice; and J. Watanabe (deceased), S. Sugano and Y. Suzuki for the construction and sequencing of the full-length cDNA library.
The authors declare no competing financial interests.
This file contains Supplementary Text Sections 1-13, Supplementary Figures and Supplementary References – see contents for details. (PDF 7979 kb)
This file contains Supplementary Tables 1-13. (XLSX 6151 kb)
This file contains Supplementary Table 13.10. (XLSX 4407 kb)
About this article
Cite this article
Tsai, I., Zarowiecki, M., Holroyd, N. et al. The genomes of four tapeworm species reveal adaptations to parasitism. Nature 496, 57–63 (2013). https://doi.org/10.1038/nature12031
Molecular characterization and immune protection of the 3-hydroxyacyl-CoA dehydrogenase gene in Echinococcus granulosus
Parasites & Vectors (2021)
Parasites & Vectors (2021)
Parasites & Vectors (2021)
In vitro effects of tropisetron and granisetron against Echinococcus granulosus (s.s.) protoscoleces by involvement of calcineurin and calmodulin
Parasites & Vectors (2021)
Transcriptome analysis uncovers the key pathways and candidate genes related to the treatment of Echinococcus granulosus protoscoleces with the repurposed drug pyronaridine
BMC Genomics (2021)